![Carla Fiankan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Carla Fiankan
Consigliere Generale presso ADVERUM BIOTECHNOLOGIES, INC.
Profilo
Carla Fiankan's current job(s) include Vice President-Regulatory at InterMune, Inc. and Vice President-Regulatory Affairs at Adverum Biotechnologies, Inc. Ms. Fiankan's former job was as Associate Director-Regulatory Affairs at Gilead Sciences, Inc. from 2003 to 2010.
Ms. Fiankan's education history includes an undergraduate degree from Notre Dame de Namur University in 1990 and a graduate degree from San Jose State University in 1993.
Posizioni attive di Carla Fiankan
Società | Posizione | Inizio |
---|---|---|
ADVERUM BIOTECHNOLOGIES, INC. | Consigliere Generale | - |
INTERMUNE INC | Consigliere Generale | 01/08/2011 |
Precedenti posizioni note di Carla Fiankan
Società | Posizione | Fine |
---|---|---|
GILEAD SCIENCES, INC. | Consigliere Generale | 01/12/2010 |
Formazione di Carla Fiankan
Notre Dame de Namur University | Undergraduate Degree |
San Jose State University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
GILEAD SCIENCES, INC. | Health Technology |
Aziende private | 1 |
---|---|
InterMune, Inc.
![]() InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Carla Fiankan